Avanos Medical Inc
AVNS11.275USD
+0.295+2.69%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
521.32MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Avanos Medical Inc Unternehmen
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Unternehmensinformationen
BörsenkürzelAVNS
Name des UnternehmensAvanos Medical Inc
IPO-datumOct 21, 2014
CEOMr. David Pacitti
Anzahl der mitarbeiter2227
WertpapierartOrdinary Share
GeschäftsjahresendeOct 21
Addresse5405 Windward Parkway
StadtALPHARETTA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl30004
Telefon18444282667
Websitehttps://avanos.com/
BörsenkürzelAVNS
IPO-datumOct 21, 2014
CEOMr. David Pacitti
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer
Chief Executive Officer
242.05K
--
Ms. Mojirade James
Ms. Mojirade James
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
132.93K
+13.98%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
71.59K
--
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Kerr W. Holbrook
Mr. Kerr W. Holbrook
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer
Chief Executive Officer
242.05K
--
Ms. Mojirade James
Ms. Mojirade James
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
132.93K
+13.98%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
71.59K
--
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Enteral feeding
74.50M
44.48%
Radiofrequency ablation
31.70M
18.93%
Neonate solutions
26.60M
15.88%
Surgical pain and recovery
24.50M
14.63%
Corporate & Other
10.20M
6.09%
Nach RegionUSD
Name
Umsatz
Anteil
North America
130.80M
78.09%
Europe, Middle East and Africa
23.70M
14.15%
Asia Pacific and Latin America
13.00M
7.76%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Enteral feeding
74.50M
44.48%
Radiofrequency ablation
31.70M
18.93%
Neonate solutions
26.60M
15.88%
Surgical pain and recovery
24.50M
14.63%
Corporate & Other
10.20M
6.09%
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
9.66%
T. Rowe Price Investment Management, Inc.
8.13%
Dimensional Fund Advisors, L.P.
5.61%
Armistice Capital LLC
4.32%
Other
58.44%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
9.66%
T. Rowe Price Investment Management, Inc.
8.13%
Dimensional Fund Advisors, L.P.
5.61%
Armistice Capital LLC
4.32%
Other
58.44%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.49%
Investment Advisor/Hedge Fund
26.84%
Hedge Fund
12.65%
Individual Investor
3.85%
Research Firm
2.44%
Pension Fund
1.13%
Family Office
1.11%
Bank and Trust
0.48%
Sovereign Wealth Fund
0.41%
Other
1.60%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
602
45.07M
97.47%
-3.44M
2025Q1
625
45.60M
98.62%
-4.71M
2024Q4
608
45.85M
99.67%
-4.42M
2024Q3
597
45.57M
99.16%
-4.09M
2024Q2
599
45.09M
98.21%
-5.57M
2024Q1
607
46.20M
99.99%
-5.04M
2023Q4
613
46.52M
100.18%
-4.77M
2023Q3
611
46.28M
98.90%
-3.96M
2023Q2
610
46.69M
100.04%
-2.11M
2023Q1
634
46.30M
99.34%
-1.85M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.40M
13.84%
-218.21K
-3.30%
Mar 31, 2025
The Vanguard Group, Inc.
5.29M
11.43%
-27.57K
-0.52%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.76M
8.13%
+746.26K
+24.78%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.60M
5.61%
+17.04K
+0.66%
Mar 31, 2025
Armistice Capital LLC
2.00M
4.32%
+2.00M
--
Mar 31, 2025
Brown Advisory
1.93M
4.18%
+26.07K
+1.37%
Mar 31, 2025
State Street Global Advisors (US)
1.93M
4.17%
-30.80K
-1.57%
Mar 31, 2025
Paradice Investment Management LLC
1.29M
2.78%
-7.17K
-0.55%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.09M
2.35%
+594.35K
+120.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.08M
2.33%
+35.44K
+3.40%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
SPDR S&P Health Care Equipment ETF
0.96%
Invesco S&P SmallCap 600 Pure Value ETF
0.53%
Invesco S&P SmallCap Health Care ETF
0.4%
Harbor Human Capital Factor US Small Cap ETF
0.34%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.28%
Royce Quant Small-Cap Quality Value ETF
0.26%
Vanguard US Value Factor ETF
0.17%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.15%
Pacer US Small Cap Cash Cows ETF
0.14%
Fidelity Enhanced Small Cap ETF
0.14%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil0.96%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.53%
Invesco S&P SmallCap Health Care ETF
Anteil0.4%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.34%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Anteil0.28%
Royce Quant Small-Cap Quality Value ETF
Anteil0.26%
Vanguard US Value Factor ETF
Anteil0.17%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.15%
Pacer US Small Cap Cash Cows ETF
Anteil0.14%
Fidelity Enhanced Small Cap ETF
Anteil0.14%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
